Retatrutide 10mg – Research Peptide

Retatrutide 10mg is supplied as a high-purity lyophilized synthetic peptide intended for laboratory research applications involving incretin receptor signaling and metabolic pathway investigation. In controlled research environments, this compound is evaluated for its interaction with GLP-1, GIP, and glucagon receptor pathways.

For a detailed laboratory comparison of receptor targeting differences and signaling characteristics, see our research overview examining Retatrutide vs Tirzepatide. Read the full comparison here.

Research Applications

Retatrutide is studied in experimental models for:

• Multi-receptor pathway activation

• Intracellular cAMP signaling dynamics

• Receptor cross-talk analysis

• Metabolic signaling cascade evaluation

Its triple receptor targeting profile distinguishes it from dual-agonist compounds examined in related laboratory research settings.

Tirzepatide

Product Specifications

• Compound: Retatrutide

• Strength: 10mg per vial

• Form: Lyophilized powder

• Purity: Research-grade (see COA)

• Storage: Refrigerated conditions recommended

• Intended Use: Laboratory Research Use Only

Certificate of Analysis

Each vial includes a QR code linking to the current Certificate of Analysis for batch verification.

Current Active Batch: # ERL-2501-B022-T

View Current COA

Research Use Notice

This compound is supplied strictly for laboratory research use only. Not for human or animal consumption

Related Metabolic Research Peptides

Researchers studying Retatrutide may also examine:

• Tirzepatide 30mg– Research Peptide

 • AOD-9604– Research Peptide

 • MOTS-C– Research Peptide